Gold Nanoparticles as Multifunctional Nanocarriers: From Drug Delivery to Photothermal Therapy
Abstract
As of late, gold nanoparticles (AuNPs) are gaining recognition as highly versatile nano-materials with remarkable potential in biomedical applications, owing to their unique physicochemical properties. Aside from their tunable size and shape and well-defined surface chemistry, AuNPs provide strong biocompatibility and distinctive optical behavior, arising from a phenomenon widely known as surface plasmon resonance (SPR). These metal nanoparticles’ ability to be coupled with therapeutic molecules, targeting ligands, and polymeric coatings is suggesting they could serve as encouraging platforms in the development of next-generation cancer treatment strategies, along other metal NPs such as silver nanoparticles (AgNPs). This review begins with a foundational overview of the physicochemical determinants of AuNP performance, including particle size, morphology, surface chemistry, and enhanced permeability and retention (EPR)-mediated targeting, before centering on the areas that most directly distinguish this review’s contribution: lipid-encapsulated and archaeal-lipid hybrid AuNP carriers, combined chemo-photothermal platforms, and NIR-I/NIR-II-responsive drug delivery systems. Comparative therapeutic performance, translational stage (in vitro, in vivo, or clinical evaluation), and manufacturing standardization are used as organizing criteria throughout, in place of a purely descriptive survey of individual platforms. At last, current translational challenges related mainly to toxicity, colloidal stability, large-scale synthesis, and clinical implementation are highlighted.